February 23, 2019

No Image

Hollywood Culture Post-Weinstein

Just in time for Oscar weekend, NPR’s Michel Martin speaks with Kim Masters, editor-at-large of The Hollywood Reporter, about the culture in Hollywood post-Harvey Weinstein.



MICHEL MARTIN, HOST:

It’s hard to imagine, but it’s been less than a year since Harvey Weinstein, the former powerhouse Hollywood producer, was arrested in New York City on rape charges. With that arrest, he became both criminal defendant and cultural symbol – catalyst for the #MeToo movement and the symbol of a culture of harassment and abuse in Hollywood and beyond.

But on this Oscar weekend, we wanted to check in to see what, if anything, has changed in Hollywood since the beginning of Me Too, so we’ve called Kim Masters. She’s an editor-at-large at the Hollywood Reporter who broke a different story about misconduct by the former head of Amazon Studios, Roy Price. Mr. Price resigned a week after her story was published. Kim Masters, welcome back. Thanks so much for joining us.

KIM MASTERS: Oh, thank you for having me.

MARTIN: So as somebody who’s covered Hollywood for a long time, have any tangible things changed since the Me Too movement?

MASTERS: You know, I wrestle with this because there is a lot of lip service paid and, you know, there is going to be, you know, agencies like ICM say we’re going to have more women, and it’s going to be 50/50 by 2020. And we all heard about the idea of an inclusion rider, or efforts to achieve greater parity – not just for women. But then we see things that are quite disheartening if you’re looking for signs of progress.

And, you know, another story I broke involved John Lasseter, who was the head of Disney Animation and Pixar Animation. And he had allegations of inappropriate conduct, and Disney ultimately moved him out. And he was rehired by – not a public company, a private company – Skydance, which is run by David Ellison. He’s the billionaire son of multibillionaire Larry Ellison.

So he can do more or less what he wants, and it feels like, with various people, there’s just an attempt to try to sort of slip back in and test the waters and see if it works. We saw it with Louis C.K. We saw it with Leslie Moonves. There’s a feeling that – are we going back to status quo ante, or are we actually seeing a change?

MARTIN: You know, people have thought that having more women in leadership roles would be one answer to this pattern.

MASTERS: That’s the hope, yeah.

MARTIN: And so are there more women in leadership roles, and is it the answer to this problem given what you just told us?

MASTERS: It is so slow, honestly. It is so slow. But we see a lot of men, white men – and every year, the statistics don’t change. And I’m not sure we’ll see after, you know, they have a chance to assess the year of Time’s Up or two years out or how long. I just feel that the culture is so entrenched. I think that progress is going to be extremely slow.

I mean, we did see Roy Price was out as the head of Amazon Studios, and Jenn Salke now runs it. She is a woman. It is a new day. Amazon very deliberately decided to give that job to a woman, so that’s one. You know, and again, when Disney replaced John Lasseter, they did put some women in more power, which had been a really big problem at Disney and Pixar Animation under John Lasseter. So, you know, there’s an attempt to say OK, well, let’s at least fix the optics. And in some cases, it’s more than that, but I’m just saying it’s really slow.

MARTIN: OK, no, you’ve given us a lot to think about, and you’ve already sort of told us a little bit about this, but is there any sort of checklist that anybody can point to in terms of looking for accountability? For example, I mean, there’s a Time’s Up organization that was founded by Hollywood women like Shonda Rhimes and Reese Witherspoon, so is there any entity that’s keeping track of progress here, or is there any way that the public can be – can hold these people accountable if they want to think about this as part of thinking about what culture they want to consume?

MASTERS: You know, I would love to end on a note of hope, but the head of Time’s Up that they hired, Lisa Borders, just left because her son has been accused of misconduct, and she is absorbed in helping to figure out what he’s going to do with this allegation. So Time’s Up has struggled a lot to figure out leadership. You know, they wanted to be very non-hierarchical, but in the end of the day, somebody needs to be in charge.

So I think we’re still, unfortunately, a ways away from having any kind of group. I mean, the unions could be helpful, but then again, they don’t necessarily address this. I mean, I think we’re – Hollywood is decentralized. Each movie is its own world – each TV show, so it’s not like we have the department of making sure that people don’t do bad things.

MARTIN: That’s Kim Masters, editor-at-large for the Hollywood Reporter. She was kind of to join us from Houston, Texas, via Skype. Kim Masters, thanks so much for talking to us.

MASTERS: Thank you for having me.

Copyright © 2019 NPR. All rights reserved. Visit our website terms of use and permissions pages at www.npr.org for further information.

NPR transcripts are created on a rush deadline by Verb8tm, Inc., an NPR contractor, and produced using a proprietary transcription process developed with NPR. This text may not be in its final form and may be updated or revised in the future. Accuracy and availability may vary. The authoritative record of NPR’s programming is the audio record.

Let’s block ads! (Why?)


No Image

Jack Davidson On Breaking An NCAA Free Throw Record

NPR’s Scott Simon talks to Jack Davidson, a student at Wabash College. He broke the NCAA record for all-time consecutive free throws. He made 95 consecutive free throws, breaking a 22-year-old record.



SCOTT SIMON, HOST:

Jack Davidson is in the record books. The sophomore at Wabash College in Indiana hit his 95th free throw in a row last Saturday in a 13-point win over Oberlin, and he established a new all-time, all-divisions NCAA record for consecutive free throws. And then he missed his next free throw. Jack Davidson joins us now from the team bus. Thanks very much for being with us, Mr. Davidson.

JACK DAVIDSON: For sure. Thanks for having me on.

SIMON: Well, congratulations. What did it feel like to make that shot?

DAVIDSON: Yeah, it was a great feeling. Just to have the crowd’s support behind you and my teammates and coaches supporting me, it was a great feeling.

SIMON: So you must have known it was coming up, right?

DAVIDSON: Yeah. We knew before the game I was at 92, and we knew it was just three more to get the record. My parents were definitely really nervous about that. And my mom actually said she had some trouble sleeping the night before because how nervous she was.

SIMON: Yeah.

DAVIDSON: But I tried to stay calm and just try to win the game and let the record take care of itself.

SIMON: So I have to ask, what happened on the next shot?

DAVIDSON: Yeah, that’s what everyone keeps asking. But honestly, I just missed it. I left it short. It is what it is. And I’m glad I could make the 95th and just miss the next one.

SIMON: I gather your record – 22-year-old record that was set by Paul Cluxton of Northern Kentucky.

DAVIDSON: Yeah.

SIMON: Have you heard from Mr. Cluxton?

DAVIDSON: Yeah. He did – he actually reached out to me the other day and texted me and congratulated me, which was pretty awesome. And also, Darnell Archey, who had the Division 1 record at Butler, gave me a call, and then we had a nice conversation. So it’s been really nice – the outreach of everyone congratulating me. And that’s been really cool.

SIMON: I did a little research. Paul Cluxton is now running a car dealership.

DAVIDSON: Is that right?

SIMON: Yeah. So what do you see in your future?

DAVIDSON: It’s hard to tell right now. I’m just trying to get a good education and see where that takes me.

SIMON: Want to play basketball in the pros?

DAVIDSON: Yeah, that’s definitely a dream of mine. To play overseas somewhere would be pretty awesome. And so I’m always going to work towards that. But for right now, I’m just not really sure what I’m going to do after college. But just trying to live each day and then try to get better in every aspect.

SIMON: There are people all over America – well, all over the world – who practice free throw shots in gyms and backyards. Any tips, since you’re kind of the ranking expert?

DAVIDSON: Yeah. I’d just say try to keep your routine simple. Don’t do anything too crazy to distract you from just making the shot.

SIMON: What do you think about those people that do it underhand?

DAVIDSON: If that works for them – you know, Rick Barry obviously had a lot of success with that.

SIMON: Yeah.

DAVIDSON: But it’s definitely, I think, probably more difficult. But if you can master that, then do what you please. But it’s definitely been easy for me shooting overhand.

SIMON: Yeah. You do have two more years to break your own record, you know?

DAVIDSON: Yeah. It would be tough to make that many in a row again, but it sure is something I could strive for to do the next two years. And that’d be pretty crazy if I got that done.

SIMON: Yeah. How many consecutive do you have now?

DAVIDSON: I think it’s just seven or eight. I missed one last game…

SIMON: Oh.

DAVIDSON: …In the middle of the game, and then I finished by making seven or eight in a row.

SIMON: OK. Well, we’ll keep an eye on it, all right?

DAVIDSON: Sounds good.

SIMON: Jack Davidson, Wabash College basketball player, thanks so much for being with us.

DAVIDSON: Yeah, thanks for having me on.

(SOUNDBITE OF MUSIC)

Copyright © 2019 NPR. All rights reserved. Visit our website terms of use and permissions pages at www.npr.org for further information.

NPR transcripts are created on a rush deadline by Verb8tm, Inc., an NPR contractor, and produced using a proprietary transcription process developed with NPR. This text may not be in its final form and may be updated or revised in the future. Accuracy and availability may vary. The authoritative record of NPR’s programming is the audio record.

Let’s block ads! (Why?)


No Image

Big Pharma Heads To Capitol Hill

The heads of the largest pharmaceutical companies will defend their pricing before the Senate next week. STAT reporter Nicholas Florko tells NPR’s Scott Simon that this will be a televised crucible.



SCOTT SIMON, HOST:

Criticism of America’s major drug companies is one of the few areas of bipartisan agreement of the U.S. Congress. Lawmakers in both parties profess to be outraged about price increases for life-saving drugs and treatments. Next Tuesday, the executives of some of the largest pharmaceutical companies in the country will go before the Senate Finance Committee. It’s expected to be a rough day for them. Nicholas Florko is the Washington correspondent for STAT, a news organization that covers health and the life sciences. He joins us in our studios. Thanks so much for being with us.

NICHOLAS FLORKO: Thanks for having me.

SIMON: Is it a little surprising they even agreed to come in?

FLORKO: Well, they really didn’t have a choice, quite frankly. If a congressional hearing – congressional committee wants to hear from you, either you come in voluntarily, or they can issue you a subpoena. And, frankly, they’re a lot nicer when you come in voluntarily.

SIMON: Can we assume the PR firms that are of counsel to all these major corporations have been working overtime to try and help them?

FLORKO: Yes, absolutely – not only PR firms but probably law firms that specialize in this as well.

SIMON: What kind of reception do you think they’re going to get?

FLORKO: It’s probably not likely that they’re going to get a friendly reception. I mean, these hearings are just as much about getting information from the drug companies as it is an opportunity for the lawmakers to make a public stand about this issue.

SIMON: I imagine no legislator thinks he or she will look very good if they say, by the way, I think price increases are great. Thank you.

FLORKO: Exactly. They realize that they are going to be on TV, the nightly news. And they want to make a point about this issue to their constituents.

SIMON: Tell us about some of the figures we’re going to be seeing – for example, Richard Gonzalez.

FLORKO: Yeah. They’re a really interesting group. So Richard Gonzalez is the CEO of the company AbbVie. Interesting company because they are not a household name, but they make a drug that’s a household name, which is Humira. You’ve probably seen the TV ads for them.

SIMON: An expensive household name.

FLORKO: Very expensive household name and on pace to be the most lucrative drug in pharmaceutical history. He is a college dropout. But he has worked his way up to CEO at AbbVie. But he’s going to face some really tough questions about these strategies the company’s used to protect this drug for so long from competition that would lower the price.

SIMON: The producer of the top-selling insulin in this country is Sanofi. I hope I’m pronouncing that correctly.

FLORKO: Yes.

SIMON: And Olivier Brandicourt.

FLORKO: That’s correct. So I call him the heel of the group because he is the one who’s going to probably face some of the toughest questions. There is bipartisan anger over the issue of insulin prices. And he is sort of No. 1 target for asking questions about why the price of insulin is so high.

SIMON: It’s essentially quadrupled for a lot of people, right?

FLORKO: That’s correct.

SIMON: Pascal Soriot of AstraZeneca.

FLORKO: So he’s my favorite of the group. My guess is if you’re going to have somebody who’s going to have a slightly embarrassing soundbite on the nightly news, it might be him. He’s kind of known for being the outspoken one, grew up in the suburbs of Paris, has talked a lot about how he used to be in fistfights as a kid. He’s actually groused to the media about how he’s the lowest paid CEO in the group, even though he makes over $12 million a year. It’s going to be interesting to see how he handles the questions that he gets.

SIMON: Whatever speeches lawmakers are going to deliver, is it a little too simplistic to hold the pharmaceutical companies responsible in and of themselves for drug prices? Because, of course, there’s a third-party payment system.

FLORKO: Yeah. I mean, it’s a super complicated area – no doubt that’s going to be the line that a lot of these companies use is you have to look at others in the supply chain. But my guess is that – obviously, the members of Congress want to hear from the drugmakers. But my guess is they want to hear from others, too. So I’d stay tuned in that round to see if there’s other hearings where we might hear from others in the supply chain.

SIMON: Pharmaceutical companies, I imagine, will also argue that you have to have, let’s say, an increasing price for insulin so they have the money to develop whatever eventually replaces insulin.

FLORKO: Of course. The issue with that argument, though – somebody like Richard Gonzalez is going to have some trouble with that because that’s a drug – his drug Humira as a reminder – that drug has been – was supposed to be eligible for generic competition a long time ago. And they’ve been accused of essentially gaming the system to keep their protection longer and longer. So the argument from lawmakers is you had your time to recoup your investment. Now it’s time to let cheaper drugs come on the market.

SIMON: Do your reportorial instincts tell you the hearing will be fair and real in attempt to discover something or just an opportunity for politicians to get soundbites?

FLORKO: It’s a little bit of both, honestly. It’s definitely going to be a show. I mean, we’ve looked at the hearings that have happened previously. You know, you had the Martin Shkreli pharma bro hearing a few years ago. And you had the EpiPen hearing about the price of that drug. There’s definitely going to be a fair bit of just grandstanding and opportunities to slam drug companies. But between the lines, these lawmakers are interested in figuring out how to legislate here. So there’ll be some interesting questions, too, that can inform legislation.

SIMON: Nicholas Florko, reporter for STAT news, thanks so much for being with us.

FLORKO: Thank you so much for having me.

Copyright © 2019 NPR. All rights reserved. Visit our website terms of use and permissions pages at www.npr.org for further information.

NPR transcripts are created on a rush deadline by Verb8tm, Inc., an NPR contractor, and produced using a proprietary transcription process developed with NPR. This text may not be in its final form and may be updated or revised in the future. Accuracy and availability may vary. The authoritative record of NPR’s programming is the audio record.

Let’s block ads! (Why?)